| dc.contributor.author | Hashimoto, T. | |
| dc.contributor.author | Ozaki, A. | |
| dc.contributor.author | Bhandari, D. | |
| dc.contributor.author | Sawano, T. | |
| dc.contributor.author | Murayama, A. | |
| dc.contributor.author | Shrestha, S. | |
| dc.contributor.author | Sah, R. | |
| dc.contributor.author | Tanimoto, T. | |
| dc.contributor.author | Montenegro-Idrogo, J.J. | |
| dc.contributor.author | Rodriguez-Morales, A.J. | |
| dc.date.accessioned | 2025-10-31T18:32:55Z | |
| dc.date.available | 2025-10-31T18:32:55Z | |
| dc.date.issued | 2021 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12805/4814 | |
| dc.description.abstract | As of early 2021, the widespread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to the emergence of more virulent genetic variants globally, which is more infectious with a high mortality rate [1,2]. Hence, a rapid elucidation of the details of SARS-CoV-2 genetic variants, their infectious capacity, and regional surveys to assess the incidence are crucial to controlling the spread of the virus. In Japan, a country early affected in the pandemic [3,4], a variant of concern 202012/01 was first identified in the airport quarantine station on December 25, 2020. Concerned about the further spread of SARS-CoV-2, the Japanese government declared a second state of emergency from January 8 to March 21, 2021. | en_US |
| dc.format | application/pdf | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier | |
| dc.relation.ispartof | urn:issn:1477-8939 | |
| dc.rights | https://purl.org/coar/access_right/c_abf2 | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | |
| dc.subject | SDG 3 | en_US |
| dc.subject | COVID-19, Its Impact, and Vaccination | en_US |
| dc.subject | COVID-19 Vaccination Certificates and Public Health Dynamics | en_US |
| dc.title | Limited capacity of SARS-CoV-2 variants testing in Japan: A secondary analysis using publicly available data | en_US |
| dc.type | https://purl.org/coar/resource_type/c_545b | |
| dc.identifier.doi | https://doi.org/10.1016/j.tmaid.2021.102145 | |
| dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.09 | |
| dc.type.other | Letter to the editor | |
| dc.identifier.journal | Travel Medicine and Infectious Disease | |
| dc.type.version | https://purl.org/coar/version/c_970fb48d4fbd8a85 | |